SlideShare a Scribd company logo
ALTERNATIVE METHODS
TO ANIMAL TOXICITY
TESTING
Saif Imtiyaz
M Pharm Pharmacology
Jamia Hamdard
PRESENTATION OUTLINES
1. Introduction…………………………………………….. 01- 02
2. The Rs Principles……………………………………… 03
3. Need For Alternatives To Animals…………………. 04
4. Alternative Methods…………………………...……… 05
5. Different alternative methods……………………….. 06- 22
6. References……………………………………………… 23
Introduction
● Animal models have been used to develop human biochemistry, physiology, pharmacology,
endocrinology, and toxicity. Every year, 10-100 million animals are used for testing.
● Animals used experimentation distributed among zebra- fish to primates. Vast majority of
animals are sacrificed at end of research programme.
● The use of animals can be further subdivided according to the degree of suffering
a. Minor animal suffering:- observing animals in behavioral studies, single blood sampling ,
immunization without adjuvants, etc.
b. Moderate animal suffering:- repeated blood sampling , recovery from general anesthesia ,
etc.
c. Severe animal suffering:- LD50% test , starvation vaccine potency tests, etc.
1
● Alternative methods to animals testing are the development and implementation of
test method that avoid use of live animals or use of less animals in method.
● The council directive on protection of animals used for experiments and scientific
purpose in Article 23
“The commission and member states should encourage research into
development and validation of alternative methods which could provide the
same level of information as that obtained in experiment using animals but
which involves less animal”.
2
The 5 R’s Principle
● Alternative methods able to do: Reduce Refine Replace ;
collectively called as “The 3Rs Principle”.
● The 3Rs principles were defined in 1959 by W.M.S Russel
and R.L Bruch. They provide a strategy for rational and
stepwise approach to minimizing animals use and
suffering in experiments without compromising the quality
and quantity of scientific work being undertaken.
● Reuse & Rehabilitate- The 4th & 5th R of Research implies
addition of ‘responsibility’ to the original three R’s, reflects
integrity, honesty, and scientific correctness in appropriate
and reasonable use of laboratory animals.
5 R’s
REDUCE
REHABILIT
ATE
REUSE
REPLACE
REFINE
3
Needs for Alternative Methods
Because in laboratory animals may be :
Poisoned
Deprived of food water and sleep
Applied with skin and eye irritants
Subjected to psychological stress
Deliberately infected with infected disease
Economic and efficiency
• Invitro testing human cell lines have been useful in securing relevant information for human risk
assessment thereby opening up opportunities to explore responses to existing and emerging
therapies human cell lines can be used for the tumor and some other chronic disease. 4
Alternative Techniques
● The term “alternative” is used to refer to those techniques or methods that replace the use of
laboratory animals altogether reduce the number of animals required or techniques to
minimize the level of stress endured by the animal.
● It is not possible to replace whole animal models with in vitro systems to evaluate drug effects
on major organ systems. However, techniques can greatly reduce the number of animals
needed, and refined protocols can improve the design efficiency and quality of studies,
and lessen stress and discomfort experienced by lab animals
● The field of alternative study particularly in vitro toxicology has evolved into a respected
discipline and is attracting competent and motivated scientist around the world.
5
Alternative to Animal Experiments
Continued but
modified use of
animals 5Rs
In vitro [test tube]
method
Tissue culture
technique
In silico
[computer
modelling
technique]
Computer aided molecular drug design [CADD]
Computer assisted learning [CAL]
Microfluidic chips
Quantitative structure activity relationship
Organ on chips
Computer or mathematic analysis
In silico
[computer
modelling
technique] 6
1. Continued But Modified Use Of Animals
Russel and Burch developed 3R’s strategy which include:
Refinement
• Refine
experimental
methods to
decrease
unnecessary
pain and
trauma to
animals.
Reduction
• Reduce the
no. of
animals used
in these
experiments
Replacement
• replace the
animal
experiments
e.g.
computer
stimulation
methods, In
vitro
methods,
Cell culture
techniques
7
Methods Of Refinement
 Providing relief [pain and distress] by giving drugs like analgesics,
anesthetics, tranquillizers and sedatives.
 By changing procedure
Modified to
reduce pain and
distress in
animal
Use non
invasive
technique like
MRI
Use less
sensitive animal
species
Use smaller
dose
Improving
housing
conditions
8
Methods Of Reduction
•Good planning of
studies Change in
experimental design
Improve methods of
data analysis
•Sharing research
animals
•Redesigning
studies to collect as
much information as
possible
•Share information.
9
Methods Of Replacement
Replace higher animals with lower animals
Replace live animals with dummies for teaching and
dissection purpose
ABSOLUTE REPLACEMENT: no need to use
animals e.g. cell lines, tissue of human or invertebrate
cell and tissue
RELATIVE REPLACEMENT: humane killing of
animals to provide cells or tissues for in vitro studies
Substitution of insentient material in place of
conscious higher animals
10
2. Invitro Models
11
• In vitro testing is the scientific analysis of the
effects of chemical substances on cultured
bacteria or mammalian cells, organ, tissues,
enzymes receptors enzymes.
• In vitro (literally 'in glass') testing methods are employed primarily : ̵ ̵ toidentify potentially
hazardous chemicals to confirm the lack of certain toxic properties in the early stages of the
development of potentially useful new substances such as therapeutic drugs, agricultural
chemicals and food additives.
• In vitro testing methods can be more useful and cost-effective than toxicology studies in
living animals (which are termed in vivo or "in life" methods).
Various Test In Vitro Methods
● In vitro pyrogen test
● Embryonic stem cell test
● Carcinogenicity test
● Neurotoxicity test
Avian chick embryo
Rodents[rat and mice, wild
type, transgenic , embryonic,
post natal , adult
Human cells [neural
progenitor cells from
aborted fetus and stem
cell lines]
Source Of Tissue For In Vitro Methods
12
3. Tissue Culture Techniques
● Tissue culture is in vitro maintenance and propagation of isolated cells, tissues or organs in
an appropriate artificial environment.
● APPLICATION OF ANIMAL CELL CULTURE
Toxicity
testing
Cancer
research
Virology Genetic
engineering
Gene
therapy
Drug
screening and
development
13
4. In silico [Computer Modelling] Techniques
● Without animal dissection computer generated stimulation are used to predict the
various possible biological and toxic effects of a chemical or potential drug candidate.
● VARIOUS TYPES IN SILICO MODELS
Computer aided molecular drug design [CADD]
Quantitative structure activity relationship
Computer assisted learning[CAL]
Computer or mathematical analysis
Organ on chips 14
A. Computer Aided Drug Design [CADD]
● It is the inventive process of finding new medications based
on the knowledge of a biological target.
● It involves the design of molecules that are complementary in
shape and charge to the biomolecular target with which they
interact and therefore will bind to it.
● It is used to predict the receptor binding site for a potential drug
molecule.
● CADD works to identify the probable binding site and hence
avoid testing of unwanted chemicals having no biological
activity. Computational approach to discover, develop and
analyze drugs.
15
● Drug design with the help of
computers may be used at any of the
following stages of drug discovery:
I. hit identification using virtual screening
(structure- or ligand-based design)
II. hit-to-lead optimization of affinity and
selectivity (structure-based design,
QSAR, etc.)
III. lead optimization: optimization of other
pharmaceutical properties while
maintaining affinity.
● Advantages of CADD
I. Time
II. Cost
III. Accuracy
IV. information about the disease
V. screening is reduced
VI. Database screening
VII. less manpower is required
16
Categories of software
Databases & Draw Tools
Molecular Modeling & Homology Modeling
Binding site prediction & Docking
Ligand design Screening -QSAR
Binding free energy estimation
ADME Toxicity 17
B. Quantitative Structure Activity Relationship
● A quantitative structure-activity relationship (QSAR) is a mathematical relationship which
correlates measurable or calculable molecular properties to some specific biological activity
in terms of an equation
● Computer programs which can predict the toxicity of new chemicals or drugs based on their
similarity to more established compounds. Principle that similar chemicals should have similar
biological properties.
● QSAR has been widely used in medicinal chemistry as support in drug’s discovery and
development process as well as in study of harmful and poisonous substances in
toxicological chemistry. QSAR attempts to find consistent relationship between biological
activity and molecular properties, so that these “rules” can be used to evaluate the activity of
new compounds
18
ADVANTAGES OF QSAR
● It gives quantifying the relationship between structure and activity with their physiochemical
property basis.
● Possible to make predictions of designed compounds before the chemical synthesis of novel
analogues.
● It may help to understand the interactions between functional group of designed molecules
and their activity of target enzyme or protein.
DISADVANTAGES OF QSAR
● Due to biological data experimental error it may give false correlations.
● If training set of molecule is less, the data may not reflect the complete property and it cannot
be used to predict the most active compounds.
● In some 3D QSAR study ligands binding receptor or protein may not be available
19
C. Organ On Chips
● It is a multichannel 3-D micro fluidic cell culture chip which simulates the activities,
mechanisms, physiological response of entire organs.
● These micro devices are translucent , they provide a window to watch inner workings of
human organs.
● Organ-on-chips that contain human cells grown in a state- of the-art system to mimic the
structure and function of human organ and organ system.
● The chips can be used instead of animals in disease research, drug testing and toxicity testing
and have been shown to replicate human physiology , diseases and drug responses more
accurately than crude animal experiments.
20
How will these organs on chips help the pharmaceutical
industries??
● Replace animal models.
● Help the laboratories reach the stage of clinical trials.
● Comparison studies of drugs on human and animals.
● To study the effect of drug on its main action of site and also other organs.
● Study of toxicity of drugs and cosmetics.
● To study about cancer cells and produce new drugs in cancer treatment.
● Ensure better regulatory decision-making.
● Develop vaccines and drugs to counter bioterrorism threats.
21
D. HET-CAM (Hen's egg-chorioallantoic membrane) TEST
● The fresh fertile white leghorn eggs are used.
● The eggs are held in optimized incubation condition.
● On day 10 inner egg membrane is removed , after careful removal the living vascular Chorio
Allantoic-Membrane is exposed.
● The test substance is dropped over CAM in a volume of 0.2- 0.3 ml and irrigated after 20 sec.
with 5ml warm water.
● The CAM, the blood vessels, including capillary system, and albumin are examined and
scored for irritant effects 0.5, 2, 5min after test compound application.
22
References
● Fundamentals of Experimental Pharmacology. M.N.Ghosh. 7th edition, 2020.
● Practical Manual of Pharmacology. Dinesh Badyal. 1st edition, 2021.
● Alternative Methods to Animal Experiments in Toxicity Testing. Nuhoğlu Öztürk, Zeyno
& Aksoy, Abdurrahman. 7th International Congress on Veterinary and Animal
Sciences (2022).
● Animal Use In Pharmacology Education And Research: The Changing Scenario.
Dinesh K. Badyal and Chetna Desai. Indian Journal of Pharmacology, May-June,
2014.
23

More Related Content

What's hot

Herg assay,Structure, Various screening methods and Advantages
Herg assay,Structure,  Various screening methods and AdvantagesHerg assay,Structure,  Various screening methods and Advantages
Herg assay,Structure, Various screening methods and Advantages
Urvashi Shakarwal
 
List of studies needed for IND submission
List of studies needed for IND submissionList of studies needed for IND submission
List of studies needed for IND submission
Shivanshu Bajaj
 
Alternative methods to animal toxicity testing
Alternative methods to animal toxicity testingAlternative methods to animal toxicity testing
Alternative methods to animal toxicity testing
Sanchit Dhankhar
 
Acute inhalational toxicity studies.pptx
 Acute inhalational toxicity studies.pptx Acute inhalational toxicity studies.pptx
Acute inhalational toxicity studies.pptx
Tanuj Silori
 
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal IrritationToxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
Shubhu20
 
Safety Pharmacology
Safety PharmacologySafety Pharmacology
Safety Pharmacology
Pavana K A
 
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
SONALPANDE5
 
Alternative to animal toxicit testing.pptx
Alternative to animal toxicit testing.pptxAlternative to animal toxicit testing.pptx
Alternative to animal toxicit testing.pptx
ANANYAPANDEY71
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
Grandhi sandeep ganesh
 
Kk Test item characterization
Kk Test item characterizationKk Test item characterization
Kk Test item characterization
Keshari Sriwastawa
 
Ind enabling studies.
Ind enabling studies.Ind enabling studies.
Ind enabling studies.
Shikha Choudhary
 
hERG Assay
hERG Assay hERG Assay
hERG Assay
VanarajRabari
 
IND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant YadavIND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant Yadav
Kashikant Yadav
 
Safety pharmacology tier 2
Safety pharmacology  tier 2Safety pharmacology  tier 2
Safety pharmacology tier 2
ragini Dani
 
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptxTOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
Anmolkanda06
 
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
helasri gummadi
 
Schedule y for toxicity studies
Schedule y  for toxicity studiesSchedule y  for toxicity studies
Schedule y for toxicity studiesKrushangiShah233
 
Alternative methods to animal toxicity testing
Alternative methods to animal toxicity testingAlternative methods to animal toxicity testing
Alternative methods to animal toxicity testing
priyachhikara1
 
Toxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptxToxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptx
ashharnomani
 
toxicokinetics and saturation kinetics
toxicokinetics and saturation kineticstoxicokinetics and saturation kinetics
toxicokinetics and saturation kinetics
pharmacistnitish
 

What's hot (20)

Herg assay,Structure, Various screening methods and Advantages
Herg assay,Structure,  Various screening methods and AdvantagesHerg assay,Structure,  Various screening methods and Advantages
Herg assay,Structure, Various screening methods and Advantages
 
List of studies needed for IND submission
List of studies needed for IND submissionList of studies needed for IND submission
List of studies needed for IND submission
 
Alternative methods to animal toxicity testing
Alternative methods to animal toxicity testingAlternative methods to animal toxicity testing
Alternative methods to animal toxicity testing
 
Acute inhalational toxicity studies.pptx
 Acute inhalational toxicity studies.pptx Acute inhalational toxicity studies.pptx
Acute inhalational toxicity studies.pptx
 
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal IrritationToxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
 
Safety Pharmacology
Safety PharmacologySafety Pharmacology
Safety Pharmacology
 
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
 
Alternative to animal toxicit testing.pptx
Alternative to animal toxicit testing.pptxAlternative to animal toxicit testing.pptx
Alternative to animal toxicit testing.pptx
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
 
Kk Test item characterization
Kk Test item characterizationKk Test item characterization
Kk Test item characterization
 
Ind enabling studies.
Ind enabling studies.Ind enabling studies.
Ind enabling studies.
 
hERG Assay
hERG Assay hERG Assay
hERG Assay
 
IND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant YadavIND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant Yadav
 
Safety pharmacology tier 2
Safety pharmacology  tier 2Safety pharmacology  tier 2
Safety pharmacology tier 2
 
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptxTOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
 
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
 
Schedule y for toxicity studies
Schedule y  for toxicity studiesSchedule y  for toxicity studies
Schedule y for toxicity studies
 
Alternative methods to animal toxicity testing
Alternative methods to animal toxicity testingAlternative methods to animal toxicity testing
Alternative methods to animal toxicity testing
 
Toxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptxToxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptx
 
toxicokinetics and saturation kinetics
toxicokinetics and saturation kineticstoxicokinetics and saturation kinetics
toxicokinetics and saturation kinetics
 

Similar to alternative methods of animal toxicity.pptx

Bioinformatic in drug designing
Bioinformatic in drug designingBioinformatic in drug designing
Bioinformatic in drug designing
Salman Khan
 
ALTERNATIVES TO ANIMAL MODELS
ALTERNATIVES TO ANIMAL MODELSALTERNATIVES TO ANIMAL MODELS
ALTERNATIVES TO ANIMAL MODELSHarish Nakka
 
Sustainability in preclinical drug discovery.pptx
Sustainability in preclinical drug discovery.pptxSustainability in preclinical drug discovery.pptx
Sustainability in preclinical drug discovery.pptx
Subramani Parasuraman
 
Alternative to invivo testing
Alternative to invivo testing Alternative to invivo testing
Alternative to invivo testing
RuchithaRao2
 
Alternative methods to animal testing: review
Alternative methods to animal testing: reviewAlternative methods to animal testing: review
Alternative methods to animal testing: review
ankit sharma
 
Alternatives to animal experiments
Alternatives to animal experimentsAlternatives to animal experiments
Alternatives to animal experimentsRoopali Somani
 
Methods of Research
Methods of Research Methods of Research
Methods of Research
Mohammad Elshawwa MD
 
Alternative to Animal Experimentation.pptx
Alternative to Animal Experimentation.pptxAlternative to Animal Experimentation.pptx
Alternative to Animal Experimentation.pptx
Ashwani Dhingra
 
Role of preclinical studies in drug discovery
Role of preclinical studies in drug discoveryRole of preclinical studies in drug discovery
Role of preclinical studies in drug discovery
Subramani Parasuraman
 
Alternatives to animalexperiments.pptx
Alternatives to animalexperiments.pptxAlternatives to animalexperiments.pptx
Alternatives to animalexperiments.pptx
Dr.SIBI P ITTIYAVIRAH
 
Role of preclinical studies in drug discovery.pptx
Role of preclinical studies in drug discovery.pptxRole of preclinical studies in drug discovery.pptx
Role of preclinical studies in drug discovery.pptx
Subramani Parasuraman
 
Alternatives to animal testing
Alternatives to animal testingAlternatives to animal testing
Alternatives to animal testing
Gandla Sowmya
 
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICALEXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
TMU
 
Role of bioinformatics of drug designing
Role of bioinformatics of drug designingRole of bioinformatics of drug designing
Role of bioinformatics of drug designing
Dr NEETHU ASOKAN
 
Alternatives to animal screening methods p'screening. mohammadhusain
Alternatives to animal screening methods p'screening. mohammadhusainAlternatives to animal screening methods p'screening. mohammadhusain
Alternatives to animal screening methods p'screening. mohammadhusainVasaya Mohammadhusain
 
Drug discovery
Drug discoveryDrug discovery
Drug discovery
Aiswarya Thomas
 
drug discovery- history, evolution and stages
drug discovery- history, evolution and stagesdrug discovery- history, evolution and stages
drug discovery- history, evolution and stages
aiswarya thomas
 
Sparsh bioinfo.ppt
Sparsh bioinfo.pptSparsh bioinfo.ppt
Sparsh bioinfo.ppt
SparshTiwari14
 
Extrapolation of in vitro data to preclinical and.pptx
Extrapolation of in vitro data to preclinical and.pptxExtrapolation of in vitro data to preclinical and.pptx
Extrapolation of in vitro data to preclinical and.pptx
ARSHIKHANAM4
 
Bioinformatics role in Pharmaceutical industries
Bioinformatics role in Pharmaceutical industriesBioinformatics role in Pharmaceutical industries
Bioinformatics role in Pharmaceutical industries
Muzna Kashaf
 

Similar to alternative methods of animal toxicity.pptx (20)

Bioinformatic in drug designing
Bioinformatic in drug designingBioinformatic in drug designing
Bioinformatic in drug designing
 
ALTERNATIVES TO ANIMAL MODELS
ALTERNATIVES TO ANIMAL MODELSALTERNATIVES TO ANIMAL MODELS
ALTERNATIVES TO ANIMAL MODELS
 
Sustainability in preclinical drug discovery.pptx
Sustainability in preclinical drug discovery.pptxSustainability in preclinical drug discovery.pptx
Sustainability in preclinical drug discovery.pptx
 
Alternative to invivo testing
Alternative to invivo testing Alternative to invivo testing
Alternative to invivo testing
 
Alternative methods to animal testing: review
Alternative methods to animal testing: reviewAlternative methods to animal testing: review
Alternative methods to animal testing: review
 
Alternatives to animal experiments
Alternatives to animal experimentsAlternatives to animal experiments
Alternatives to animal experiments
 
Methods of Research
Methods of Research Methods of Research
Methods of Research
 
Alternative to Animal Experimentation.pptx
Alternative to Animal Experimentation.pptxAlternative to Animal Experimentation.pptx
Alternative to Animal Experimentation.pptx
 
Role of preclinical studies in drug discovery
Role of preclinical studies in drug discoveryRole of preclinical studies in drug discovery
Role of preclinical studies in drug discovery
 
Alternatives to animalexperiments.pptx
Alternatives to animalexperiments.pptxAlternatives to animalexperiments.pptx
Alternatives to animalexperiments.pptx
 
Role of preclinical studies in drug discovery.pptx
Role of preclinical studies in drug discovery.pptxRole of preclinical studies in drug discovery.pptx
Role of preclinical studies in drug discovery.pptx
 
Alternatives to animal testing
Alternatives to animal testingAlternatives to animal testing
Alternatives to animal testing
 
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICALEXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
 
Role of bioinformatics of drug designing
Role of bioinformatics of drug designingRole of bioinformatics of drug designing
Role of bioinformatics of drug designing
 
Alternatives to animal screening methods p'screening. mohammadhusain
Alternatives to animal screening methods p'screening. mohammadhusainAlternatives to animal screening methods p'screening. mohammadhusain
Alternatives to animal screening methods p'screening. mohammadhusain
 
Drug discovery
Drug discoveryDrug discovery
Drug discovery
 
drug discovery- history, evolution and stages
drug discovery- history, evolution and stagesdrug discovery- history, evolution and stages
drug discovery- history, evolution and stages
 
Sparsh bioinfo.ppt
Sparsh bioinfo.pptSparsh bioinfo.ppt
Sparsh bioinfo.ppt
 
Extrapolation of in vitro data to preclinical and.pptx
Extrapolation of in vitro data to preclinical and.pptxExtrapolation of in vitro data to preclinical and.pptx
Extrapolation of in vitro data to preclinical and.pptx
 
Bioinformatics role in Pharmaceutical industries
Bioinformatics role in Pharmaceutical industriesBioinformatics role in Pharmaceutical industries
Bioinformatics role in Pharmaceutical industries
 

More from ashharnomani

Protein microarray .pptx
Protein microarray .pptxProtein microarray .pptx
Protein microarray .pptx
ashharnomani
 
Nucleic acid microarray.pptx
Nucleic acid microarray.pptxNucleic acid microarray.pptx
Nucleic acid microarray.pptx
ashharnomani
 
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptx
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptxMETHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptx
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptx
ashharnomani
 
Computational Prediction Of Protein-1.pptx
Computational Prediction Of Protein-1.pptxComputational Prediction Of Protein-1.pptx
Computational Prediction Of Protein-1.pptx
ashharnomani
 
INFLAMMATION.pptx
INFLAMMATION.pptxINFLAMMATION.pptx
INFLAMMATION.pptx
ashharnomani
 
hit identification.pptx
hit identification.pptxhit identification.pptx
hit identification.pptx
ashharnomani
 
Oral contraceptives.pptx
Oral contraceptives.pptxOral contraceptives.pptx
Oral contraceptives.pptx
ashharnomani
 
Methods in Rational Drug design.pptx
Methods in Rational Drug design.pptxMethods in Rational Drug design.pptx
Methods in Rational Drug design.pptx
ashharnomani
 
pharmacophoremapping05-180503150916-converted.pptx
pharmacophoremapping05-180503150916-converted.pptxpharmacophoremapping05-180503150916-converted.pptx
pharmacophoremapping05-180503150916-converted.pptx
ashharnomani
 
Terminologies In OECD Guidelines.pptx
Terminologies In OECD Guidelines.pptxTerminologies In OECD Guidelines.pptx
Terminologies In OECD Guidelines.pptx
ashharnomani
 
WHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptxWHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptx
ashharnomani
 
Teratogenicity.pptx
Teratogenicity.pptxTeratogenicity.pptx
Teratogenicity.pptx
ashharnomani
 
ANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptxANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptx
ashharnomani
 
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptxSPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
ashharnomani
 
progesterone receptor.pptx
progesterone receptor.pptxprogesterone receptor.pptx
progesterone receptor.pptx
ashharnomani
 
GH RECEPTORS.pptx
GH RECEPTORS.pptxGH RECEPTORS.pptx
GH RECEPTORS.pptx
ashharnomani
 
antihelminthic.ppt
antihelminthic.pptantihelminthic.ppt
antihelminthic.ppt
ashharnomani
 
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptx
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptxestablishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptx
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptx
ashharnomani
 
ANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptxANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptx
ashharnomani
 
Calcium regulation.pptx
Calcium regulation.pptxCalcium regulation.pptx
Calcium regulation.pptx
ashharnomani
 

More from ashharnomani (20)

Protein microarray .pptx
Protein microarray .pptxProtein microarray .pptx
Protein microarray .pptx
 
Nucleic acid microarray.pptx
Nucleic acid microarray.pptxNucleic acid microarray.pptx
Nucleic acid microarray.pptx
 
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptx
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptxMETHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptx
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptx
 
Computational Prediction Of Protein-1.pptx
Computational Prediction Of Protein-1.pptxComputational Prediction Of Protein-1.pptx
Computational Prediction Of Protein-1.pptx
 
INFLAMMATION.pptx
INFLAMMATION.pptxINFLAMMATION.pptx
INFLAMMATION.pptx
 
hit identification.pptx
hit identification.pptxhit identification.pptx
hit identification.pptx
 
Oral contraceptives.pptx
Oral contraceptives.pptxOral contraceptives.pptx
Oral contraceptives.pptx
 
Methods in Rational Drug design.pptx
Methods in Rational Drug design.pptxMethods in Rational Drug design.pptx
Methods in Rational Drug design.pptx
 
pharmacophoremapping05-180503150916-converted.pptx
pharmacophoremapping05-180503150916-converted.pptxpharmacophoremapping05-180503150916-converted.pptx
pharmacophoremapping05-180503150916-converted.pptx
 
Terminologies In OECD Guidelines.pptx
Terminologies In OECD Guidelines.pptxTerminologies In OECD Guidelines.pptx
Terminologies In OECD Guidelines.pptx
 
WHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptxWHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptx
 
Teratogenicity.pptx
Teratogenicity.pptxTeratogenicity.pptx
Teratogenicity.pptx
 
ANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptxANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptx
 
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptxSPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
 
progesterone receptor.pptx
progesterone receptor.pptxprogesterone receptor.pptx
progesterone receptor.pptx
 
GH RECEPTORS.pptx
GH RECEPTORS.pptxGH RECEPTORS.pptx
GH RECEPTORS.pptx
 
antihelminthic.ppt
antihelminthic.pptantihelminthic.ppt
antihelminthic.ppt
 
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptx
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptxestablishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptx
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptx
 
ANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptxANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptx
 
Calcium regulation.pptx
Calcium regulation.pptxCalcium regulation.pptx
Calcium regulation.pptx
 

Recently uploaded

Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
bennyroshan06
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
Steve Thomason
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
PedroFerreira53928
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
Fundacja Rozwoju Społeczeństwa Przedsiębiorczego
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
Celine George
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
Col Mukteshwar Prasad
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
Excellence Foundation for South Sudan
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
rosedainty
 

Recently uploaded (20)

Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
 

alternative methods of animal toxicity.pptx

  • 1. ALTERNATIVE METHODS TO ANIMAL TOXICITY TESTING Saif Imtiyaz M Pharm Pharmacology Jamia Hamdard
  • 2. PRESENTATION OUTLINES 1. Introduction…………………………………………….. 01- 02 2. The Rs Principles……………………………………… 03 3. Need For Alternatives To Animals…………………. 04 4. Alternative Methods…………………………...……… 05 5. Different alternative methods……………………….. 06- 22 6. References……………………………………………… 23
  • 3. Introduction ● Animal models have been used to develop human biochemistry, physiology, pharmacology, endocrinology, and toxicity. Every year, 10-100 million animals are used for testing. ● Animals used experimentation distributed among zebra- fish to primates. Vast majority of animals are sacrificed at end of research programme. ● The use of animals can be further subdivided according to the degree of suffering a. Minor animal suffering:- observing animals in behavioral studies, single blood sampling , immunization without adjuvants, etc. b. Moderate animal suffering:- repeated blood sampling , recovery from general anesthesia , etc. c. Severe animal suffering:- LD50% test , starvation vaccine potency tests, etc. 1
  • 4. ● Alternative methods to animals testing are the development and implementation of test method that avoid use of live animals or use of less animals in method. ● The council directive on protection of animals used for experiments and scientific purpose in Article 23 “The commission and member states should encourage research into development and validation of alternative methods which could provide the same level of information as that obtained in experiment using animals but which involves less animal”. 2
  • 5. The 5 R’s Principle ● Alternative methods able to do: Reduce Refine Replace ; collectively called as “The 3Rs Principle”. ● The 3Rs principles were defined in 1959 by W.M.S Russel and R.L Bruch. They provide a strategy for rational and stepwise approach to minimizing animals use and suffering in experiments without compromising the quality and quantity of scientific work being undertaken. ● Reuse & Rehabilitate- The 4th & 5th R of Research implies addition of ‘responsibility’ to the original three R’s, reflects integrity, honesty, and scientific correctness in appropriate and reasonable use of laboratory animals. 5 R’s REDUCE REHABILIT ATE REUSE REPLACE REFINE 3
  • 6. Needs for Alternative Methods Because in laboratory animals may be : Poisoned Deprived of food water and sleep Applied with skin and eye irritants Subjected to psychological stress Deliberately infected with infected disease Economic and efficiency • Invitro testing human cell lines have been useful in securing relevant information for human risk assessment thereby opening up opportunities to explore responses to existing and emerging therapies human cell lines can be used for the tumor and some other chronic disease. 4
  • 7. Alternative Techniques ● The term “alternative” is used to refer to those techniques or methods that replace the use of laboratory animals altogether reduce the number of animals required or techniques to minimize the level of stress endured by the animal. ● It is not possible to replace whole animal models with in vitro systems to evaluate drug effects on major organ systems. However, techniques can greatly reduce the number of animals needed, and refined protocols can improve the design efficiency and quality of studies, and lessen stress and discomfort experienced by lab animals ● The field of alternative study particularly in vitro toxicology has evolved into a respected discipline and is attracting competent and motivated scientist around the world. 5
  • 8. Alternative to Animal Experiments Continued but modified use of animals 5Rs In vitro [test tube] method Tissue culture technique In silico [computer modelling technique] Computer aided molecular drug design [CADD] Computer assisted learning [CAL] Microfluidic chips Quantitative structure activity relationship Organ on chips Computer or mathematic analysis In silico [computer modelling technique] 6
  • 9. 1. Continued But Modified Use Of Animals Russel and Burch developed 3R’s strategy which include: Refinement • Refine experimental methods to decrease unnecessary pain and trauma to animals. Reduction • Reduce the no. of animals used in these experiments Replacement • replace the animal experiments e.g. computer stimulation methods, In vitro methods, Cell culture techniques 7
  • 10. Methods Of Refinement  Providing relief [pain and distress] by giving drugs like analgesics, anesthetics, tranquillizers and sedatives.  By changing procedure Modified to reduce pain and distress in animal Use non invasive technique like MRI Use less sensitive animal species Use smaller dose Improving housing conditions 8
  • 11. Methods Of Reduction •Good planning of studies Change in experimental design Improve methods of data analysis •Sharing research animals •Redesigning studies to collect as much information as possible •Share information. 9
  • 12. Methods Of Replacement Replace higher animals with lower animals Replace live animals with dummies for teaching and dissection purpose ABSOLUTE REPLACEMENT: no need to use animals e.g. cell lines, tissue of human or invertebrate cell and tissue RELATIVE REPLACEMENT: humane killing of animals to provide cells or tissues for in vitro studies Substitution of insentient material in place of conscious higher animals 10
  • 13. 2. Invitro Models 11 • In vitro testing is the scientific analysis of the effects of chemical substances on cultured bacteria or mammalian cells, organ, tissues, enzymes receptors enzymes. • In vitro (literally 'in glass') testing methods are employed primarily : ̵ ̵ toidentify potentially hazardous chemicals to confirm the lack of certain toxic properties in the early stages of the development of potentially useful new substances such as therapeutic drugs, agricultural chemicals and food additives. • In vitro testing methods can be more useful and cost-effective than toxicology studies in living animals (which are termed in vivo or "in life" methods).
  • 14. Various Test In Vitro Methods ● In vitro pyrogen test ● Embryonic stem cell test ● Carcinogenicity test ● Neurotoxicity test Avian chick embryo Rodents[rat and mice, wild type, transgenic , embryonic, post natal , adult Human cells [neural progenitor cells from aborted fetus and stem cell lines] Source Of Tissue For In Vitro Methods 12
  • 15. 3. Tissue Culture Techniques ● Tissue culture is in vitro maintenance and propagation of isolated cells, tissues or organs in an appropriate artificial environment. ● APPLICATION OF ANIMAL CELL CULTURE Toxicity testing Cancer research Virology Genetic engineering Gene therapy Drug screening and development 13
  • 16. 4. In silico [Computer Modelling] Techniques ● Without animal dissection computer generated stimulation are used to predict the various possible biological and toxic effects of a chemical or potential drug candidate. ● VARIOUS TYPES IN SILICO MODELS Computer aided molecular drug design [CADD] Quantitative structure activity relationship Computer assisted learning[CAL] Computer or mathematical analysis Organ on chips 14
  • 17. A. Computer Aided Drug Design [CADD] ● It is the inventive process of finding new medications based on the knowledge of a biological target. ● It involves the design of molecules that are complementary in shape and charge to the biomolecular target with which they interact and therefore will bind to it. ● It is used to predict the receptor binding site for a potential drug molecule. ● CADD works to identify the probable binding site and hence avoid testing of unwanted chemicals having no biological activity. Computational approach to discover, develop and analyze drugs. 15
  • 18. ● Drug design with the help of computers may be used at any of the following stages of drug discovery: I. hit identification using virtual screening (structure- or ligand-based design) II. hit-to-lead optimization of affinity and selectivity (structure-based design, QSAR, etc.) III. lead optimization: optimization of other pharmaceutical properties while maintaining affinity. ● Advantages of CADD I. Time II. Cost III. Accuracy IV. information about the disease V. screening is reduced VI. Database screening VII. less manpower is required 16
  • 19. Categories of software Databases & Draw Tools Molecular Modeling & Homology Modeling Binding site prediction & Docking Ligand design Screening -QSAR Binding free energy estimation ADME Toxicity 17
  • 20. B. Quantitative Structure Activity Relationship ● A quantitative structure-activity relationship (QSAR) is a mathematical relationship which correlates measurable or calculable molecular properties to some specific biological activity in terms of an equation ● Computer programs which can predict the toxicity of new chemicals or drugs based on their similarity to more established compounds. Principle that similar chemicals should have similar biological properties. ● QSAR has been widely used in medicinal chemistry as support in drug’s discovery and development process as well as in study of harmful and poisonous substances in toxicological chemistry. QSAR attempts to find consistent relationship between biological activity and molecular properties, so that these “rules” can be used to evaluate the activity of new compounds 18
  • 21. ADVANTAGES OF QSAR ● It gives quantifying the relationship between structure and activity with their physiochemical property basis. ● Possible to make predictions of designed compounds before the chemical synthesis of novel analogues. ● It may help to understand the interactions between functional group of designed molecules and their activity of target enzyme or protein. DISADVANTAGES OF QSAR ● Due to biological data experimental error it may give false correlations. ● If training set of molecule is less, the data may not reflect the complete property and it cannot be used to predict the most active compounds. ● In some 3D QSAR study ligands binding receptor or protein may not be available 19
  • 22. C. Organ On Chips ● It is a multichannel 3-D micro fluidic cell culture chip which simulates the activities, mechanisms, physiological response of entire organs. ● These micro devices are translucent , they provide a window to watch inner workings of human organs. ● Organ-on-chips that contain human cells grown in a state- of the-art system to mimic the structure and function of human organ and organ system. ● The chips can be used instead of animals in disease research, drug testing and toxicity testing and have been shown to replicate human physiology , diseases and drug responses more accurately than crude animal experiments. 20
  • 23. How will these organs on chips help the pharmaceutical industries?? ● Replace animal models. ● Help the laboratories reach the stage of clinical trials. ● Comparison studies of drugs on human and animals. ● To study the effect of drug on its main action of site and also other organs. ● Study of toxicity of drugs and cosmetics. ● To study about cancer cells and produce new drugs in cancer treatment. ● Ensure better regulatory decision-making. ● Develop vaccines and drugs to counter bioterrorism threats. 21
  • 24. D. HET-CAM (Hen's egg-chorioallantoic membrane) TEST ● The fresh fertile white leghorn eggs are used. ● The eggs are held in optimized incubation condition. ● On day 10 inner egg membrane is removed , after careful removal the living vascular Chorio Allantoic-Membrane is exposed. ● The test substance is dropped over CAM in a volume of 0.2- 0.3 ml and irrigated after 20 sec. with 5ml warm water. ● The CAM, the blood vessels, including capillary system, and albumin are examined and scored for irritant effects 0.5, 2, 5min after test compound application. 22
  • 25. References ● Fundamentals of Experimental Pharmacology. M.N.Ghosh. 7th edition, 2020. ● Practical Manual of Pharmacology. Dinesh Badyal. 1st edition, 2021. ● Alternative Methods to Animal Experiments in Toxicity Testing. Nuhoğlu Öztürk, Zeyno & Aksoy, Abdurrahman. 7th International Congress on Veterinary and Animal Sciences (2022). ● Animal Use In Pharmacology Education And Research: The Changing Scenario. Dinesh K. Badyal and Chetna Desai. Indian Journal of Pharmacology, May-June, 2014. 23